Atrial fibrillation and primary care prevention and rehabilitation - a feasibility study. [PDF]
Elnegaard CM +9 more
europepmc +1 more source
P-293 Performance of low energy pulsed truncated exponential biphasic shocks for electroconversion of paroxysmal atrial fibrillation of less than 48 hour duration [PDF]
Andrej Pernat +3 more
openalex +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Atrial Fibrillation in Advanced CKD: To Anticoagulate, or Not, and With What? [PDF]
Ajmal MS, Winkelmayer WC.
europepmc +1 more source
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi +9 more
wiley +1 more source
Balancing clinical responsibilities and research during electrophysiology fellowship
Panteleimon E. Papakonstantinou, MD, MSc, PhD, FESC
doaj +1 more source
Comment on “Management of Atrial Fibrillation in Critically Ill Patients” [PDF]
Roger W. Jelliffe
openalex +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
Circulating mitochondrial cell-free DNA levels are associated with the recurrence of atrial fibrillation after catheter ablation for atrial fibrillation. [PDF]
Takahashi T +19 more
europepmc +1 more source

